ARENTFOX SCHIFF LLP

Lobbying for PHARVARIS, INC. · Late-stage biopharmaceutical company

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · Massachusetts · House · Senate · $40,000.00 income · posted Apr 17, 2026

Lobbying activity 2

Medicare/Medicaid

Advocacy of policies, legislation and coverage of new pharmaceuticals in the orphan drug space.

Pharmacy

Advocacy of policies, legislation and regulation pertaining to pharmaceutical manufacturing, focusing on orphan drug production.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.